At the time of writing, Inspire Medical Systems Inc [INSP] stock is trading at $95.99, up 4.77%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The INSP shares have gain 9.37% over the last week, with a monthly amount drifted -25.38%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Inspire Medical Systems Inc [NYSE: INSP] stock has seen the most recent analyst activity on August 05, 2025, when Truist downgraded its rating to a Hold but kept the price target unchanged to $125 for it. Previously, KeyBanc Capital Markets downgraded its rating to Sector Weight on August 05, 2025. On August 05, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $110 on the stock. BofA Securities upgraded its rating to a Buy and increased its price target to $255 on November 20, 2024. BofA Securities downgraded its rating to a Neutral and reduced its price target to $225 on May 08, 2024. RBC Capital Mkts started tracking with a Outperform rating for this stock on April 19, 2024, and assigned it a price target of $285. In a note dated March 19, 2024, Morgan Stanley initiated an Overweight rating and provided a target price of $250 on this stock.
For the past year, the stock price of Inspire Medical Systems Inc fluctuated between $73.92 and $225.00. Currently, Wall Street analysts expect the stock to reach $172.86 within the next 12 months. Inspire Medical Systems Inc [NYSE: INSP] shares were valued at $95.99 at the most recent close of the market. An investor can expect a potential return of 80.08% based on the average INSP price forecast.
Analyzing the INSP fundamentals
According to Inspire Medical Systems Inc [NYSE:INSP], the company’s sales were 861.31M for trailing twelve months, which represents an 10.82% jump. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.08 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 93.12 points at the first support level, and at 90.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 97.46, and for the 2nd resistance point, it is at 98.94.
Ratios To Look Out For
It is important to note that Inspire Medical Systems Inc [NYSE:INSP] has a current ratio of 6.14. Further, the Quick Ratio stands at 4.84, while the Cash Ratio is 1.15. Considering the valuation of this stock, the price to sales ratio is 3.30, the price to book ratio is 4.19 and price to earnings (TTM) ratio is 55.61.
Transactions by insiders
Recent insider trading involved Rondoni John, that happened on May 19 ’25 when 1734.0 shares were sold. Officer, JOHN RONDONI completed a deal on May 19 ’25 to buy 1734.0 shares. Meanwhile, Director mcCormick Shawn sold 360.0 shares on May 02 ’25.
